EUVIMEDUpptäck EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Saponins and Sapogenins in Inflammation Therapeutics: Glycosylation‐Dependent Mechanisms, Pharmacokinetics and Advanced Delivery Solutions

Meilin Qin, Yuyang Fu, Boyu Wang, Aimei Liu, Sibusiso Luthuli, Hanfei Wang iD, Liwei Guo iD, Xuejun Gao iD

Phytotherapy Research · 2026-11-16

DOI: 10.1002/ptr.70526 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, published online on 2026-11-16. Written by Meilin Qin and 7 co-authors. Institution: College of Animal Science and Technology, Yangtze University, Jingzhou, Hubei, China. 64 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Hubei Key Laboratory of Waterlogging Disaster and Agricultural Use of Wetland, Scientific Research Plan Project of the Education Department of Hubei Province, Key Laboratory of Prevention and Control Agents for Animal Bacteriosis (Ministry of Agriculture and Rural Affairs).

AbstractSubjectsBibliografiska uppgifterCiteRelated studies

Abstract (original language)

Saponins and their aglycones, the sapogenins, are the bioactive constituents of medicinal herbs such as Panax ginseng and Astragalus membranaceus , and they act on inflammation at several levels at once. The canonical nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB), mitogen‐activated protein kinase (MAPK), and NLR family pyrin domain‐containing 3 (NLRP3) inflammasome cascades are the best‐replicated entry points, and beyond them these compounds modify non‐coding RNA networks and post‐translational regulation and reshape immuno‐metabolic circuits by suppressing glycolytic enzymes and engaging AMPK‐dependent energy sensing. Whether a given activity belongs to the glycoside or to the aglycone is often unclear, because orally administered glycosides are extensively deglycosylated by the intestinal microbiota, and this review therefore organises the evidence by glycosylation status and annotates every compound accordingly. Translation is constrained by poor aqueous solubility, low and variable bioavailability, structural instability, and dose‐dependent toxicity, and stimulus‐responsive nanocarriers, exosome‐based systems, and microbiota‐aware pharmacokinetic modelling are the most credible routes past these barriers. The mechanistic picture that emerges is coherent but still provisional, and progress now depends less on further pathway catalogues than on experiments that establish direct target engagement and on pharmacokinetic‐pharmacodynamic data obtained in human‐relevant models.

Subjects

Author keywords

anti‐inflammatory mechanismschronic inflammatory diseasesdrug delivery systemsepigenetic regulationglycosylationimmuno‐metabolic reprogrammingsapogeninssaponins

Authors and institutions

  • College of Animal Science and Technology, Yangtze University, Jingzhou, Hubei, China.
  • National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei, China.
  • School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei, China.
  • Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, China.
  • Center for Cross-Disciplinary in Animal Epidemic and Public Health, Hubei Jiangxia Laboratory, Wuhan, Hubei, China.

ORCID profiles: Hanfei Wang, Liwei Guo, Xuejun Gao

Funding

  • Hubei Key Laboratory of Waterlogging Disaster and Agricultural Use of Wetland
  • Scientific Research Plan Project of the Education Department of Hubei Province
  • Key Laboratory of Prevention and Control Agents for Animal Bacteriosis (Ministry of Agriculture and Rural Affairs)
  • Hubei Provincial Key Laboratory of Animal Pathogenic Microbiology
  • Ministry of Agriculture and Rural Affairs of the People's Republic of China

Cite

APA

Qin, M., Fu, Y., Wang, B., Liu, A., Luthuli, S., Wang, H., Guo, L., & Gao, X. (2026). Saponins and Sapogenins in Inflammation Therapeutics: Glycosylation‐Dependent Mechanisms, Pharmacokinetics and Advanced Delivery Solutions. Phytotherapy Research. https://doi.org/10.1002/ptr.70526

Vancouver

Qin M, Fu Y, Wang B, Liu A, Luthuli S, Wang H, et al. Saponins and Sapogenins in Inflammation Therapeutics: Glycosylation‐Dependent Mechanisms, Pharmacokinetics and Advanced Delivery Solutions. Phytotherapy Research. 2026. doi:10.1002/ptr.70526

BibTeX
@article{Qin2026,
  author = {Qin, Meilin and Fu, Yuyang and Wang, Boyu and Liu, Aimei and Luthuli, Sibusiso and Wang, Hanfei and Guo, Liwei and Gao, Xuejun},
  title = {Saponins and Sapogenins in Inflammation Therapeutics: Glycosylation‐Dependent Mechanisms, Pharmacokinetics and Advanced Delivery Solutions},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70526}
}
Start for free →